TY - JOUR
T1 - Predictors of Intensive Treatment in Patients With Obsessive-Compulsive Disorder
AU - du Mortier, Johanna A.M.
AU - Remmerswaal, Karin C.P.
AU - Batelaan, Neeltje M.
AU - Visser, Henny A.D.
AU - Twisk, Jos W.R.
AU - van Oppen, Patricia
AU - van Balkom, Anton J.L.M.
N1 - Funding Information: Funding. The research infrastructure needed to complete the baseline measurements (including personnel and materials) has been financed almost exclusively by the participating organizations (Academic Department of Psychiatry, UMC/GGZ inGeest, Amsterdam, the Netherlands; Marina de Wolf Centre for Anxiety Research, Ermelo; Centre for Anxiety Disorders Overwaal, Lent; Dimence, GGZ Overijssel; Department of Psychiatry, Leiden University Medical Centre, Leiden; Mental Health Care Centre Noord- en Midden-Limburg, Venray; Academic Anxiety Centre, PsyQ Maastricht, Maastricht University, Division Mental Health and Neuroscience). The fieldwork coordinator was financed for 1 year by a research grant from the Stichting Steun. Funding Information: The research infrastructure needed to complete the baseline measurements (including personnel and materials) has been financed almost exclusively by the participating organizations (Academic Department of Psychiatry, UMC/GGZ inGeest, Amsterdam, the Netherlands; Marina de Wolf Centre for Anxiety Research, Ermelo; Centre for Anxiety Disorders Overwaal, Lent; Dimence, GGZ Overijssel; Department of Psychiatry, Leiden University Medical Centre, Leiden; Mental Health Care Centre Noord-en Midden-Limburg, Venray; Academic Anxiety Centre, PsyQ Maastricht, Maastricht University, Division Mental Health and Neuroscience). The fieldwork coordinator was financed for 1 year by a research grant from the Stichting Steun. Publisher Copyright: © Copyright © 2021 du Mortier, Remmerswaal, Batelaan, Visser, Twisk, van Oppen and van Balkom. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/4/12
Y1 - 2021/4/12
N2 - Background: Few studies have investigated which patients with obsessive-compulsive disorder (OCD) do not recover through regular cognitive behavior therapy or pharmacotherapy and subsequently end up in intensive treatment like day treatment or inpatient treatment. Knowing the predictors of intensive treatment in these patients is significant because it could prevent intensive treatment. This study has identified predictors of intensive treatment in patients with OCD. Methods: Using 6-year longitudinal data of the Netherlands Obsessive Compulsive Disorder Association (NOCDA), potential predictors of intensive treatment were assessed in patients with OCD (n = 419). Intensive treatment was assessed using the Treatment Inventory Costs in Patients with Psychiatric Disorders (TIC-P). Examined potential predictors were: sociodemographics, and clinical and psychosocial characteristics. Logistic Generalized Estimating Equations was used to estimate to what extent the various characteristics (at baseline, 2- and 4-year assessment) predicted intensive treatment in the following 2 years, averaged over the three assessment periods. Results: Being single, more severe comorbid depression, use of psychotropic medication, and a low quality of life predicted intensive treatment in the following 2 years. Conclusions: Therapists should be aware that patients with OCD who are single, who have more severe comorbid depression, who use psychotropic medication, and who have a low quality of life or a drop in quality of life are at risk for intensive treatment. Intensive treatment might be prevented by focusing regular treatment not only on OCD symptoms but also on comorbid depression and on quality of life. Intensive treatment might be improved by providing extra support in treatment or by adjusting treatment to impairments due to comorbid depressive symptoms or a low quality of life.
AB - Background: Few studies have investigated which patients with obsessive-compulsive disorder (OCD) do not recover through regular cognitive behavior therapy or pharmacotherapy and subsequently end up in intensive treatment like day treatment or inpatient treatment. Knowing the predictors of intensive treatment in these patients is significant because it could prevent intensive treatment. This study has identified predictors of intensive treatment in patients with OCD. Methods: Using 6-year longitudinal data of the Netherlands Obsessive Compulsive Disorder Association (NOCDA), potential predictors of intensive treatment were assessed in patients with OCD (n = 419). Intensive treatment was assessed using the Treatment Inventory Costs in Patients with Psychiatric Disorders (TIC-P). Examined potential predictors were: sociodemographics, and clinical and psychosocial characteristics. Logistic Generalized Estimating Equations was used to estimate to what extent the various characteristics (at baseline, 2- and 4-year assessment) predicted intensive treatment in the following 2 years, averaged over the three assessment periods. Results: Being single, more severe comorbid depression, use of psychotropic medication, and a low quality of life predicted intensive treatment in the following 2 years. Conclusions: Therapists should be aware that patients with OCD who are single, who have more severe comorbid depression, who use psychotropic medication, and who have a low quality of life or a drop in quality of life are at risk for intensive treatment. Intensive treatment might be prevented by focusing regular treatment not only on OCD symptoms but also on comorbid depression and on quality of life. Intensive treatment might be improved by providing extra support in treatment or by adjusting treatment to impairments due to comorbid depressive symptoms or a low quality of life.
KW - OCD
KW - comorbid depression
KW - intensive treatment
KW - longitudinal
KW - obsessive-compulsive disorder
KW - psychotropic medication
KW - quality of life
UR - http://www.scopus.com/inward/record.url?scp=85104950128&partnerID=8YFLogxK
U2 - https://doi.org/10.3389/fpsyt.2021.659401
DO - https://doi.org/10.3389/fpsyt.2021.659401
M3 - Article
C2 - 33912087
SN - 1664-0640
VL - 12
JO - Frontiers in psychiatry
JF - Frontiers in psychiatry
M1 - 659401
ER -